Form:	Canary: PASS Follow-up Biopsy v2.0

CDE ID	CDE Description
* 421	EDRN Participant ID (Go To: 973)
* 973	Date of prostate biopsy (MM/DD/YYYY): (Go To: 423)
* 423	EDRN Protocol ID (Go To: 422)
* 422	EDRN Site ID (Go To: 929)
* 929	EDRN Staff ID of the person who collected the data: (Go To: 578)
* 578	Age at specimen collection (Go To: 839)
839	ID number of local pathology report: (Go To: 2714)
* 2714	Procedure performed at the study site? (Go To: 2174)
	Permissible Values (value): No (0)
	Yes (1)
	Unknown (99)
2174	Indication for current prostate biopsy (Check all that apply.) (Go To: 1581)
	Permissible Values (value): Rising PSA (1)
	Elevated PSA (2)
	Abnormal DRE (3)
	Abnormal biopsy (4)
	Atypical small acinar proliferation (ASAP) (6)
	Family history (7)
	High grade PIN (8)
	Surveillance biopsy (9)
	Suspicious MRI (27)
	Other, specify: (97) (Go To: 1578)
1578	Indication for prostate biopsy, other specify: (Go To: 1581)
1581	Hypoechoic or suspicious foci seen? (Go To: 1692)
	Permissible Values (value): No (0)
	Yes (1)
* 1692	Prostate size (by TRUS): (Go To: 980)
* 980	Total number of cores taken: (Go To: 2872)
* 2872	Total number of cores with cancer: (Go To: 4538)
	Permissible Values (value): 0 (0)
	1 (1)
	2 (2)
	3 (3)
	4 (4)
	5 (5)
	6 (6)
	7 (7)
	8 (8)
	9 (9)
	10 (10)
	11 (11)
	12 (12)
	13 (13)
	14 (14)
	15 (15)
	16 (16)
	17 (17)
	18 (18)
	19 (19)
	20 (20)
	>20 (40)
	Unknown (99)
4538	Number of systematic cores: (Go To: 4540)
4540	Number of targeted cores: (Go To: 4541)
* 4541	Was a MRI/US Fusion Biopsy performed? (Go To: 2158)
	Permissible Values (value): No (0)
	Yes (1) (Go To: 955)
	No, in-gantry (2)
	Unknown (99)
955	Date of imaging test (MM/DD/YYYY): (Go To: 2158)
* 2158	Number of specimens: (Go To: 2159)
* 2159	Specimen line number or identifier (system-generated): (Go To: 2709)
* 2709	Specimen identifier: (Go To: 2160)
* 2160	Tissue position (laterality): (Go To: 2211)
	Permissible Values (value): Right (1)
	Left (2)
	Unknown/refused (99)
2211	Tissue position (zone): (Go To: 2213)
	Permissible Values (value): Transition Zone (TZ) (1)
	Seminal vesicle (2)
	Anterior zone (3)
	Posterior zone (5)
2213	Tissue position (regionality): (Go To: 2212)
	Permissible Values (value): Apex (A) (1)
	Middle (M) (2)
	Base (B) (3)
2212	Tissue position (position within region): (Go To: 4539)
	Permissible Values (value): Lateral (lat) (1)
	Medial (med) (2)
4539	Type of tissue targeting (Go To: 2207)
	Permissible Values (value): No (0)
	Yes (1)
	Unknown (99)
* 2207	Is the tissue normal? (Go To: 2210)
	Permissible Values (value): No (0)
	Yes (1) (Go To: 1097)
2210	Percent of cancer in tissue: (Go To: 2209)
2209	Length of tissue specimen (mm): (Go To: 2208)
2208	Length of cancer in tissue specimen (mm): (Go To: 984)
984	High grade prostatic intraepithelial neoplasia (PIN)? (Go To: 1596)
	Permissible Values (value): No (0)
	Yes (1)
1596	Atypical small acinar proliferation (ASAP)? (Go To: 1591)
	Permissible Values (value): No (0)
	Yes (1)
1591	Perineural invasion: (Go To: 4596)
	Permissible Values (value): Present (1)
	Absent (2)
4596	ISUP prostate histopathologic grade: (Go To: 1589)
	Permissible Values (value): Grade Group 1 (1)
	Grade Group 2 (2)
	Grade Group 3 (3)
	Grade Group 4 (4)
	Grade Group 5 (5)
	Not applicable (98)
* 1589	Primary Gleason grade: (Go To: 1590)
* 1590	Secondary Gleason grade: (Go To: 1696)
1696	Tertiary Gleason Pattern: (Go To: 1697)
1697	Overall Gleason Score: (Go To: 1097)
1097	Comments (do not include any participant identifiers) (Go To: End of Form)